<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yoon CI</submitter><funding>NRF</funding><funding>Ministry of Science, ICT, &amp;amp; Future Planning</funding><funding>Ministry of Health &amp;amp; Welfare, Republic of Korea</funding><funding>National R&amp;amp;D Program for Cancer Control</funding><pagination>141-148</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7375640</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>50</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Tumor-infiltrating lymphocytes (TILs) might be associated with host-cell mediated immunity, which could be partly reflected by peripheral blood cell counts. In addition, lymphocyte-predominant breast cancer (LPBC), which was defined as tumors having high TIL levels, showed a favorable prognosis among triple-negative breast cancer or HER2-positive breast cancer. We aimed to investigate whether peripheral blood cell counts are associated with LPBC.&lt;h4>Methods&lt;/h4>We evaluated the percentage of stromal TILs in breast cancer patients who underwent primary surgery, using the standardized methodology proposed by the international TIL Working Group. Lymphocyte-predominant breast cancer (LPBC) was defined as tumors having high TIL levels (≥50%). Peripheral blood cell counts including absolute neutrophil counts (ANC), absolute lymphocyte counts (ALC) and neutrophil-to-lymphocyte ratio (NLR) was obtained from pretreatment laboratory data.&lt;h4>Result&lt;/h4>Of the 810 patients, 132 (16.3%) had LPBC, and 678 (83.7%) had non-LBPC. In a comparison of 3 markers of peripheral blood counts, LPBC had a significantly lower mean ANC than non-LPBC (3,304 vs. 3,564; P = 0.023), but the other means were not different. In multivariable analysis, each 1K increment in ANC corresponded to an odds ratio of 0.790 (95% CI, 0.642 to 0.971) for LPBC. In the ER-negative and high-Ki67 subgroups identified by interaction tests, significant inverse correlations between continuous ANC and TILs were noted.&lt;h4>Conclusion&lt;/h4>Low peripheral ANC could be linked with LPBC, supporting the hypothesis that systemic immune cell counts might be associated with the tumor-immune microenvironment.</pubmed_abstract><journal>Breast (Edinburgh, Scotland)</journal><pubmed_title>Associations between absolute neutrophil count and lymphocyte-predominant breast cancer.</pubmed_title><pmcid>PMC7375640</pmcid><funding_grant_id>1520120</funding_grant_id><funding_grant_id>NRF-2019R1C1C1002830</funding_grant_id><pubmed_authors>Jeong J</pubmed_authors><pubmed_authors>Yoon CI</pubmed_authors><pubmed_authors>Lee HS</pubmed_authors><pubmed_authors>Bae SJ</pubmed_authors><pubmed_authors>Lee DY</pubmed_authors><pubmed_authors>Ahn SG</pubmed_authors><pubmed_authors>Park S</pubmed_authors><pubmed_authors>Cha YJ</pubmed_authors><pubmed_authors>Cha C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Associations between absolute neutrophil count and lymphocyte-predominant breast cancer.</name><description>&lt;h4>Introduction&lt;/h4>Tumor-infiltrating lymphocytes (TILs) might be associated with host-cell mediated immunity, which could be partly reflected by peripheral blood cell counts. In addition, lymphocyte-predominant breast cancer (LPBC), which was defined as tumors having high TIL levels, showed a favorable prognosis among triple-negative breast cancer or HER2-positive breast cancer. We aimed to investigate whether peripheral blood cell counts are associated with LPBC.&lt;h4>Methods&lt;/h4>We evaluated the percentage of stromal TILs in breast cancer patients who underwent primary surgery, using the standardized methodology proposed by the international TIL Working Group. Lymphocyte-predominant breast cancer (LPBC) was defined as tumors having high TIL levels (≥50%). Peripheral blood cell counts including absolute neutrophil counts (ANC), absolute lymphocyte counts (ALC) and neutrophil-to-lymphocyte ratio (NLR) was obtained from pretreatment laboratory data.&lt;h4>Result&lt;/h4>Of the 810 patients, 132 (16.3%) had LPBC, and 678 (83.7%) had non-LBPC. In a comparison of 3 markers of peripheral blood counts, LPBC had a significantly lower mean ANC than non-LPBC (3,304 vs. 3,564; P = 0.023), but the other means were not different. In multivariable analysis, each 1K increment in ANC corresponded to an odds ratio of 0.790 (95% CI, 0.642 to 0.971) for LPBC. In the ER-negative and high-Ki67 subgroups identified by interaction tests, significant inverse correlations between continuous ANC and TILs were noted.&lt;h4>Conclusion&lt;/h4>Low peripheral ANC could be linked with LPBC, supporting the hypothesis that systemic immune cell counts might be associated with the tumor-immune microenvironment.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Apr</publication><modification>2025-04-19T11:38:27.717Z</modification><creation>2025-04-19T11:38:27.717Z</creation></dates><accession>S-EPMC7375640</accession><cross_references><pubmed>31607527</pubmed><doi>10.1016/j.breast.2019.09.013</doi></cross_references></HashMap>